INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 129 filers reported holding INTERSECT ENT INC in Q2 2017. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $986,000 | -12.7% | 57,500 | -38.4% | 0.02% | -14.3% |
| Q4 2016 | $1,130,000 | -42.3% | 93,400 | -24.4% | 0.02% | -40.0% |
| Q3 2016 | $1,958,000 | -10.4% | 123,600 | -26.9% | 0.04% | -12.5% |
| Q2 2016 | $2,186,000 | -9.7% | 169,100 | +32.7% | 0.04% | -4.8% |
| Q1 2016 | $2,421,000 | +28.6% | 127,400 | +52.2% | 0.04% | +35.5% |
| Q4 2015 | $1,883,000 | +1.5% | 83,700 | +5.5% | 0.03% | +6.9% |
| Q3 2015 | $1,856,000 | -59.3% | 79,300 | -50.2% | 0.03% | -53.2% |
| Q2 2015 | $4,561,000 | +6.8% | 159,300 | -3.6% | 0.06% | +19.2% |
| Q1 2015 | $4,270,000 | +68.0% | 165,300 | +20.7% | 0.05% | +73.3% |
| Q4 2014 | $2,541,000 | +17.1% | 137,000 | -2.1% | 0.03% | +20.0% |
| Q3 2014 | $2,170,000 | – | 140,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |